| Financial Year |
March 31 2023 |
| Monetary Funds |
498,163,529.15 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
127,688,084.79 |
| Accounts Receivable |
648,636,828.10 |
| Advances to Suppliers |
26,879,121.61 |
| Other Receivables |
6,538,135.91 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
382,097,011.24 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
85,756,218.04 |
| Other Current Assets |
8,861,297.09 |
| Total Current Assets |
1,836,248,673.95 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
502,074,908.80 |
| Investment Properties |
23,762,270.06 |
| Fixed Assetes |
524,605,860.83 |
| Under-construction Projects |
73,167,830.79 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
91,880,572.74 |
| R&D expenses |
-- |
| Goodwill |
460,038.82 |
| Long-Term Deferred and Prepaid Expenses |
2,190,016.60 |
| Deferred Income Tax Assets |
9,743,083.11 |
| Other Non-Current Assets |
53,389,459.90 |
| Sub-Total of Non-Current Assets |
1,614,393,759.27 |
| Total Assets |
3,450,642,433.22 |
| Short-Term Loans |
4,873,360.25 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
255,204,490.14 |
| Accounts Received In Advance |
9,123.20 |
| Employee Compensation Payable |
6,976,679.88 |
| Taxes Payable |
11,645,703.69 |
| Interest Payable |
-- |
| Dividend Payable |
661,245.08 |
| Other payables |
76,026,128.88 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
388,419.92 |
| Other Current Liabilities |
47,349,202.73 |
| Sub-Total of Current Liabilities |
488,931,881.95 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
3,775,829.39 |
| Special Payable |
-- |
| Estimatied Liabilities |
8,489,203.54 |
| Deferred Income Tax Liabilities |
3,060,852.82 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
40,316,501.90 |
| Total Liabilities |
529,248,383.85 |
| Paid-In Capital(Or Share Stock) |
404,311,320.00 |
| Capital Surplus |
870,850,523.92 |
| Surplus Reserve |
280,602,577.67 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,287,726,169.79 |
| Minority Stockholder's Interest |
68,434,859.72 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,852,959,189.65 |
| Owner's Equity（Stockholder's Equity） |
2,921,394,049.37 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,450,642,433.22 |
